OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the American Academy of Child and Adolescent Psychiatry is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Hats Off: Journal Awards 2022	152
Editorial: Outcome Measurement in Pediatric Obsessive-Compulsive Disorder: Current Considerations and Future Directions	145
Editorial Board Page	140
Table of Contents	90
Council Page	81
Koro-Like Symptoms in an Adolescent Female With Schizophrenia	79
The Mental Health Effects of Migrant Family Separation	74
Editorial: Time to Recognize Nonverbal Learning Disability to Foster Advances in Its Research	73
Table of Contents	73
Table of Contents	69
Brief Behavioral Therapy for Anxiety and Depression in Pediatric Primary Care: Breadth of Intervention Impact	66
Editorial: Why Are Children Hurting Themselves and What Can We Do?	66
We Hear You	65
Editors’ Note: Second Annual Report Regarding JAACAP’s Antiracist Journey	64
Navigating the Rollercoaster Ride of Adolescence	63
Effect of Esketamine on Depressive Symptoms in Adolescents with Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study	61
Nonsuicidal Self-injury and Barriers to Accessibility of Dialectical Behavior Therapy Among Black Youth	58
In Context: A Developmental Model of Reward Processing, With Implications for Autism and Sensitive Periods	58
Table of Contents	54
Editorial Board Page	52
Editorial: Conduct Disorder and Its 70-Year History: Lessons From Hervey Cleckley and Lee Robins	52
James C. Harris, MD (1940-2021)	52
3.22 Executive Function in ADHD and ASD: A Scoping Review	47
14.3 Psychopharmacology Management: Mood Instability and Impulsive Aggression in Youth With ASD	46
21.4 THE TEXAS CHILD MENTAL HEALTH CARE CONSORTIUM: BRINGING ACADEMIC EXPERTISE TO THE PUBLIC HEALTH ARENA	45

THE MANY FACES OF PEDIATRIC CATATONIA: BEYOND WAXY FLEXIBILITY AND ECHO PHENOMENA	45
3.17 The Impact of Executive Functioning Deficit on Illness Severity in Patients With an ADHD Diagnosis: A Real-World Data Study	45
14.1 Phenomenology and Management of Self-Injurious Behavior in ASD	44
3.1 Population Pharmacokinetic-Pharmacodynamic Modeling of Variable Wear Times for a Dextroamphetamine Transdermal System	43
3.21 A New Objective Diagnostic Tool for ADHD: Development of the Web-Based Auditory-Focused Continuous Performance Test	42
YOUNG, BLACK, AND QUEER: ADDRESSING INTERSECTIONAL IDENTITIES IN TRAUMA AND RESILIENCE INTERVENTIONS	41
13.1 Setting the Stage: Overview of Tourette's Disorder	40
17.2 From Learner to Teacher and Back: The Consult-Liaison Learning Environment from the Triple Board Perspective	40
3.11 The Role of ADHD in Individuals With OCD Alone and OCD Plus Hoarding	39
3.9 What Are the Benefits and Harms of Methylphenidate Treatment in Children and Adolescents With ADHD?	39
EVIDENCE-BASED SCREENING, ASSESSMENT, AND TREATMENT OF SEXUALLY ABUSED CHILDREN: A MULTIDISCIPLINARY PERSPECTIVE	38
3.4 Barriers and Facilitators to Implementing a Canadian Shared-Care ADHD Program in a Behavioral Pediatric Setting in Shanghai: A Consolidated Framework for an Implementation Research Approach	38
24.2 EVIDENCE-BASED TOOLS FOR SCREENING AND ASSESSMENT OF CHILDHOOD SEXUAL ABUSE	38
3.12 Reading Without Eye Movements: Improving Reading Comprehension in Young Adults With ADHD	37
STICKS, STONES, AND WORDS DO HURT: IT TAKES A VILLAGE TO RESPOND TO BULLYING	37
19.1 Popular Film as a Tool for Cultural Humility: Asian American Film as Case Study	36
3.26 Demographic and Clinical Characteristics of Pediatric Inpatients With Somatic Symptom and Related Disorders, in a Reference Center in Medellin, Colombia	36
3.24 Exergaming Using Obie® and its Effect in Improving Executive Function Deficits in Children With Fetal Alcohol Spectrum Disorder and Comorbid ADHD: An Exploratory Study	36
3.51 School-Age Diagnostic ASD Assessments: A Pilot Clinic for Child and Adolescent Psychiatry Fellows	36
23.1 LGBTQ PARENTING: WHERE HAVE WE BEEN? WHERE ARE WE? WHERE ARE WE GOING?	36
28.1 UNA OPORTUNIDAD PARA ENTENDERNOS: THE IMPORTANCE OF SPANISH LANGUAGE CONCORDANCE	35
3.31 Now Screening—Suicidality and ASD: Can the Emergency Department Play a Leading Role?	35
19.2 How Do We Care for, Talk to, and Fight With Each Other?: Exercising Cultural Humility for an Immigrant Family	34
COVID-19 AND TIC DISORDERS: A STORY IN MOTION	34
21.2 All Hands on Deck: A Call for Collaboration Between Pediatrics and Psychiatry in Working With Gender-Diverse Youth	34
3.53 Validation of a Youth Self-Report and Parent-Report Version of the Autism Spectrum Quotient Questionnaire (AQ-28)	33
25.4 CRISIS PREVENTIONS AND INTERVENTIONS FOR CHILDREN WITH INTELLECTUAL DEVELOPMENTAL DISORDERS (IDDS): MODIFICATION TO SYSTEMIC, THERAPEUTIC, ASSESSMENT, RESOURCES, AND TREATMENT (START) DURING COVI	33
"MY KID’S ALWAYS ONLINE, BUT WHAT CAN I DO ABOUT IT?" HELPING FAMILIES MANAGE MEDIA	33
3.42 The Reliability and Validity of the Turkish Version of the Autism Family Experience Questionnaire (AFEQ)	31
SEXUALITY IN INDIVIDUALS WITH INTELLECTUAL DEVELOPMENTAL DISORDERS: DEVELOPMENT, GENDER, AND VULNERABILITY	31
31.2 MINING THE MEANING OF THE MULTISITE MULTIMODAL TREATMENT STUDY OF ADHD (MTA) STUDY: NOVEL FINDINGS FROM QUALITATIVE STUDY METHODS	31
30.2 CAN TEENAGERS’ SMARTPHONES REVEAL HOW THEY ARE REALLY DOING? DIVING INTO THE PROS, CONS, AND ETHICS OF USING DIGITAL PHENOTYPING IN THE CLINICAL PRACTICE OF CHILD PSYCHIATRY	31
3.76 Intolerance of Uncertainty and Depression During the COVID-19 Pandemic in New York	30
28.3 Catatonia in Children and Adolescents with ASD	29
26.1 Is That Normal? What Do We Do?	29
SPARE THE ROD, SPOIL THE CHILD: ADDRESSING CORPORAL PUNISHMENT ACROSS CULTURES AND CONTEXTS	28
31.2 When and How to Incorporate Genetic Testing Into Child and Adolescent Psychiatry (second presenter)	28
PEDIATRIC MEDICINE UPDATE: COVID-19: VIROLOGY, VACCINES, AND PEDIATRIC ILLNESS	28
28.2 The Diagnosis and Grading of Catatonia Using Clinical Rating Scales	28
28.2 SHOULD WE DO IT BECAUSE WE CAN? THE ETHICS OF PREDICTING AUTISM SPECTRUM DISORDER IN INFANCY	27
IMPROVING THE CONCEPTUALIZATION, IDENTIFICATION, AND DIAGNOSIS OF TRAUMATIZED CHILDREN, YOUTH, AND FAMILIES	27
3.96 Identifying Preschool-Age Moderating Factors in the Development of Borderline Personality Disorder	26
Author Index	26
40.1 THE USE AND ABUSE OF STIMULANTS IN CHILDREN AND ADOLESCENTS IN THE UNITED STATES AND THAILAND	26
IMPROVEMENTS IN EMOTIONAL LABILITY WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE TREATMENT IN CHILDREN WITH ADHD	26
2.60 How Much Is Too Much?: A Review of Current Treatments for Catatonia	25
1.1 Sleep Disorders in Youth With ASD	25
EFFICACY OF LONG-TERM TREATMENT WITH VILOXAZINE EXTENDED-RELEASE CAPSULES (QELBREE™) IN CHILDREN AND ADOLESCENTS WITH ADHD: AN OPEN-LABEL EXTENSION STUDY	25
BLACK FATHERS' KNOWLEDGE AND ATTITUDES ABOUT TOXIC STRESS	25
AN UPDATE ON COMMON COMORBIDITIES IN ASD: SLEEP DISORDERS, ANXIETY, BODY-FOCUSED REPETITIVE BEHAVIORS, AND IRRITABILITY	24

2.100 Identifying Gaps in Provider Knowledge: Trainees Less Comfortable With Suicide Assessment in Youth with ASD and Intellectual Disability	24
MENTAL HEALTH INTEGRATION WITH PRIMARY CARE: UNIQUE OPPORTUNITIES AND RESPONSES IN THE FACE OF A GLOBAL PANDEMIC	24
2.75 Longitudinal Associations Between Digital Media Use and Psychotic Experiences in Youth From the Community	24
2.97 Trends in Asian American and Pacific Islander Youth Suicide from 1999 to 2019	24
9.2 HOW MUCH SCREEN TIME IS TOO MUCH?	23
CHILD AND ADOLESCENT TELE-PARTIAL HOSPITALIZATION PROGRAMS (TELE-PHP): OPPORTUNITIES AND CHALLENGES	23
2.78 Experiences of Young People Receiving Early Psychosis Intervention Services Virtually: A Mixed-Methods Evaluation	23
2.80 The Role of Participating in Extracurricular Activities and School Sports on Child and Youth Mental Health During the COVID-19 Pandemic	23
OPENING PANDEMIC’S BOX: SUPPORTING DEVELOPING ADOLESCENTS	23
THE NEW NORMAL: DIVERSE FAMILY SYSTEMS AND THEIR ROLES IN IDENTITY FORMATION IN ADOLESCENTS	23
2.92 Internet-Related Problems Contributing to Acute Psychiatric Crises and Hospitalizations Among Children and Adolescents Before and After the Onset of the COVID-19 Pandemic	22
2.112 Detection of Emergency Department Visits for Youth Suicide and Self-Harm Using Electronic Health Records	21
3.125 Suicide Risk Assessment for Children and Adolescents Checklist (SRACC): A Medical Procedural Checklist and a Teaching Tool for Residency Programs	21
6.2 Rethinking Trauma and Diagnosis in the Context of Child Psychological Maltreatment: The Critical Role of Child and Adolescent Psychiatrists in Ending the Oppression of Children and Youth of Color	21
5.4 Integrating Pharmacogenomic Results Into Clinical Care: Now What?	21
RECOGNIZING AND RESPONDING TO PSYCHOLOGICAL MALTREATMENT: ROLE OF THE CHILD AND ADOLESCENT PSYCHIATRIST IN WORKING WITH THE CHILD WELFARE SYSTEM	20
53.3 TEACHING ADHD TO PHYSICIANS IN EL SALVADOR	20
53.1 TEACHING ADHD TO INDIAN TEACHERS AND PARENTS	20
42.3 Finding Water in the Desert: Accessing Educational Resources, Identifying Available Technology-Based Treatment Tools, and Finding Higher Levels of Care in Rural Communities	20
Author Index	20
Table of Contents	20
51.3 SPACE: SUPPORTIVE PARENTING FOR ANXIOUS CHILDHOOD EMOTIONS	20
52.2 AN UPDATE ON GENE-MEDICATION INTERACTIONS RELEVANT TO PEDIATRIC PSYCHOPHARMACOTHERAPY	20
3.130 An Assessment of Eating Disorder Complications in Transgender and Gender-Nonconforming Youths	20
42.4 Screening, Brief Intervention, and Referral to Treatment (SBIRT) in Rural School Districts: Barriers and Facilitators to Its Implementation	20
2.110 Characterizing High-Risk Adolescents’ Disclosures of Suicidal Thoughts and Behaviors	19
THERAPIST SELF-DISCLOSURE (TSD) DURING TIMES OF UNCERTAINTY	19
THE PEDIATRIC-CHILD PSYCHIATRY ALLIANCE: IMPLEMENTING A BLUEPRINT FOR YOUTH SUICIDE PREVENTION	19
2.131 Adverse Childhood Experiences in Pakistan: A Call for Action	19
CLINICAL PERSPECTIVES: OUTPATIENT MANAGEMENT OF IMPULSIVITY, HYPERACTIVITY, AND AGGRESSION IN YOUNG CHILDREN (AGES 2-7)	18
12.2 Cultural and Familial Considerations for the Informed Consent Model	18
20.2 DEVELOPMENT OF A CLINICAL PATHWAY FOR CHILDREN AND ADOLESCENTS WITH IDENTIFIED SUICIDE RISK	18
18.4 THERAPIST SELF-DISCLOSURE (TSD) AND TRAINEE SUPERVISION	18
67.1 RECOGNIZING THE PREVALENCE OF TRAUMA IN CHILDREN WITH INTELLECTUAL DEVELOPMENTAL DISORDERS (IDDS)	18
17.2 THE AUTISM SPECTRUM DISORDER AND INTELLECTUAL DISABILITY (ASD/ID) RESOURCE PAGE ON AACAP.ORG: TECHNOLOGY ENHANCES TRAINING IN ASD AND ID	18
20.3 IMPROVING PEDIATRIC PROVIDERS’ ATTITUDES IN CARING FOR YOUTH AT RISK FOR SUICIDE BY TRAINING USING STANDARDIZED PATIENTS AND ZERO SUICIDE CONCEPTS	18
15.1 ANGRY YOUNG MEN, COMMON THREADS IN DIFFERENT TYPES OF EXTREMIST GROUPS	18
66.1 PREPARATION BEFORE PRESCRIBING BUPRENORPHINE: WHAT DO I NEED TO DO?	18
21.3 BECOMING CHAMPIONS FOR CHILD MENTAL HEALTH ACCESS: LESSONS FROM IMPLEMENTING A CHILD PSYCHIATRY ACCESS PROGRAM IN MISSISSIPPI	18
2.134 HETEROGENEITY OF BRAIN STRUCTURES AND PSYCHIATRIC SYMPTOM PATTERNS IN DISRUPTIVE MOOD AND BEHAVIOR DISORDERS	18
31.3 Providing Psychiatric Care for Children With Genetic Disorders of Neurodevelopment: A New Era in Child and Adolescent Psychiatry	17
3.103 Stimulant-Induced Psychosis in Adolescents in State Wards	17
3.111 Psychiatric Impacts of the COVID-19 Global Pandemic on US Sexual and Gender Minority (SGM) Young Adults	17
39.3 FINDING THE ENTRY POINTS FOR LIBERATION-BASED HEALING IN YOUR PRACTICE	17
31.1 When and How to Incorporate Genetic Testing into Child and Adolescent Psychiatry	17
31.1 VARIABLE PATTERNS OF REMISSION FROM ADHD IN THE MULTIMODAL TREATMENT STUDY OF ADHD (MTA)	17
CHILDREN’S NARRATIVES OF FORCED MIGRATION: CULTURAL FACTORS, RESILIENCE, AND TREATMENT CONSIDERATIONS FOR CHILDREN AT THE BORDER	16
6.1 ENHANCING THE MODEL: TELEPSYCHIATRY WITHIN EMERGENCY CARE AT CHILDREN’S HOSPITAL COLORADO	16
4.4 Social Media Contagion in Adolescents	16
3.105 A 10-Year Data Analysis of Sexual and Domestic Violence Against Children and Adolescents in Korea	16
82.2 I Sent the Recommended Fragile X Test and Chromosomal Microarray: Now What?	16
1.1 FEDERAL INITIATIVES TO ADDRESS INEQUITIES IN OUTCOMES AND ACCESS IN MENTAL HEALTH CARE FOR YOUTH WITH SERIOUS EMOTIONAL DISTURBANCE	15
AFTER SUBSTANCE SCREENING, BRIEF INTERVENTION, AND REFERRAL TO TREATMENT (SBIRT): YOU’VE SCREENED, NOW WHAT?	15
CULTURAL INFLUENCES ON FATHER-CHILD RELATIONSHIPS FROM AROUND THE WORLD	15
60.3 Dream Big: The International Pursuit of American Equal Opportunity	15
73.2 FAMILY THERAPY AND SAFETY PLANNING IN THE INPATIENT PSYCHIATRIC UNIT	15
72.4 THE ROLE OF HEALTHCARE DISPARITIES AND SOCIAL JUSTICE ISSUES IN RESIDENTIAL PLACEMENT	15
73.1 “I’M SUICIDAL BECAUSE OF ISSUES AT HOME”: WHAT PSYCHIATRISTS CAN DO FOR CHILDREN AND FAMILIES IN THE EMERGENCY DEPARTMENT	15
2.79 School Modality and Learning Contexts During COVID-19: Implications for Child and Youth Mental Health	15
74.1 EARLY-LIFE TRAUMA AND SUBSTANCE USE	14
1.3 INTERSECTION OF RACE AND ETHNICITY WITH MENTAL HEALTH SERVICE UTILIZATION IN FOSTER CARE YOUTH	14
MESSY AND EFFECTIVE: DIGGING INTO FAMILY-BASED APPROACHES	14
66.2 From Grandfather to Father: Exploring Indian Fatherhood Through Intergenerational Communication	14
3.1 CLINICAL PROFILE OF PSYCHIATRICALLY REFERRED YOUTH WITH AUTISM SPECTRUM DISORDER	14
AUTOIMMUNE BRAIN DISORDERS: ADVANCING THE STANDARD OF CARE	14
66.1 What Healthcare Providers Need to Know About Fatherhood in El Salvador	14
67.1 Mindful Parenting	14
56.1 Associations Between Young Children’s Screen Time and Child Outcomes: A Series of Meta-Analyses	13
BEYOND THE BASICS: PRESCRIBING PRACTICES AND CLINICAL CHALLENGES IN EARLY PSYCHOSIS	13
60.4 PORN IN THE USA: HOW SEXUALLY EXPLICIT MEDIA AFFECTS MENTAL HEALTH AND RISK BEHAVIORS	13
COMMON PSYCHIATRIC COMORBIDITIES IN AUTISM SPECTRUM DISORDER: ADHD, ANXIETY, DEPRESSION, AND CATATONIA	13
LOVE IN QUARANTINE: ADDRESSING ONLINE SEXUAL BEHAVIORS IN CLINICAL PRACTICE	13
52.4 Therapist Self-Disclosure With Children and Adolescents With ASD	13
51.1 Inspired Supervision and Mentorship: Creating a Semi-Structured Curriculum for Faculty Development That Enhances Psychotherapy Supervision and Trainee Teaching	13
50.3 Away From the Table: Inpatient and Medical Interventions for Severe Eating Disorders	13
62.1 INTRODUCTION TO TRANSPLANTATION: FROM LISTING TO PSYCHOSOCIAL ASSESSMENT	13
58.2 MOOD AND BEHAVIORAL ACTIVATION ASSOCIATED WITH SSRIS IN CHILDREN AND ADOLESCENTS WITH AUTISM SPECTRUM DISORDER	13
53.1 Cyberbullying: Introduction, Definition, and Impact on Mental Health in Youth	13
BUPRENORPHINE TRAINING 2.0: NEXT STEPS AFTER WAIVER	12
2.121 A Needs Assessment of Cyberbullying Curricula in Psychiatry Residency Training	12

HOW TO IMPLEMENT MEASUREMENT-BASED PRACTICE (MBP) IN CHILD AND ADOLESCENT INPATIENT UNIT: BENEFITS AND OBSTACLES	12
65.1 PSYCHODYNAMIC PSYCHOPHARMACOLOGY CURRICULUM FOR CHILD AND ADOLESCENT PSYCHIATRY	12
55.2 Long-Acting Injectables and Pediatric Psychotic Disorders	12
56.3 “Would You Say My Child Is Addicted?”: Lending Principles of Addiction Treatment to Families and Adolescents Worried About Social Media	12
55.4 Know Your CYPs! Meaningful Cytochrome p450 Interactions in the Treatment of Psychosis	12
3.4 Diverse Family Structures: Featuring Multiracial Families	11
MAINTAINING PERSONAL WELLNESS: A REVIEW OF THE PROBLEM AND PRACTICAL SOLUTIONS	11
HARNESSING CHILD AND ADOLESCENT PSYCHIATRY EXPERTISE THROUGH BEHAVIORAL HEALTH EDUCATION IN COLLABORATIVE CARE PROGRAMS AND PEDIATRICS RESIDENCY TRAINING INTERVENTIONS	11
6.3 SPECIFYING OPPORTUNITY TO RESOLVE RACE-BASED MENTAL HEALTH INEQUITY IN EARLY CHILDHOOD	11
7.3 Intersectional Suicide Prevention for LGBTQ Youth at the Trevor Project	11
4.7 PERSONAL EXPERIENCES OF SAFETY ASSESSMENT: STUDENT AND FAMILY VOICES	11
8.3 GENETIC CONDITIONS ASSOCIATED WITH INTELLECTUAL DEVELOPMENTAL DISORDERS	11
2.4 “Boys Shed Blood, Not Tears”: The Influence of Masculinity in East Asia and for Sexual and Gender Minorities	11
4.6 DIGITAL DANGERS: HOW TO THINK ABOUT INCORPORATING ASSESSMENT OF DIGITAL MEDIA INTO SCHOOL THREAT ASSESSMENTS	11
3.5 BALANCING RISK AND BENEFIT IN MANAGING IRRITABILITY AND AGITATION IN AUTISM SPECTRUM DISORDER	11
16.1 GENETIC TESTING IN AN INPATIENT CHILD AND ADOLESCENT PSYCHIATRY SETTING	11
79.4 Cultural Considerations in Family-Based Treatments of Eating Disorders	10
2.3 Results of the ICD-11 Clinic-Based Field Study of Mental and Behavioral Disorders in Children and Adolescents – Part 2: Clinical Utility and Implementation Characteristics Across 4 Countries	10
8.5 CO-OCCURRING MEDICAL ISSUES IN INTELLECTUAL DEVELOPMENTAL DISORDERS: MANAGEMENT OF PATIENTS WITHIN MULTIDISCIPLINARY TEAMS	10
1.3 Supporting the Mental Health Needs of Unaccompanied Children in THE Office of Refugee Resettlement Care	10
6.5 Diagnosis and Treatment of Mental Illness as Seen Through the Lens of Genetics: Today and Tomorrow	10
78.1 Mental Health Impacts of Climate Change on Circumpolar Indigenous Peoples	10
79.1 The Vermont Family-Based Approach	10
6.3 Evaluation of Early-Onset Psychosis Should include Genetic Testing	10
8.2 PSYCHIATRIC DISORDERS IN CHILDREN AND ADOLESCENTS WITH INTELLECTUAL DEVELOPMENTAL DISORDER	10
72.1 Phenomenology and Epidemiology of Asian American Youths With AN Eating Disorder	10
7.1 Developmental Language Disorders: Implications for Clinical Practice	10
8.1 REVIEW OF PROGRESS IN THE CLASSIFICATION OF INTELLECTUAL DEVELOPMENTAL DISORDER IN DSM-5	10
71.4 Texas Tech Health Sciences Center El Paso: Child and Adolescent Psychiatry, Education, and Community	10
10.1 PRECLINICAL MODELING OF THE METABOLIC AND SKELETAL EFFECTS OF ATYPICAL ANTIPSYCHOTIC MEDICATIONS	10
8.3 KETAMINE FOR PEDIATRIC TREATMENT-RESISTANT DEPRESSION: SAFETY, EFFICACY, AND DEVELOPMENTAL CONSIDERATIONS	10
7.7 THE PHARMACOLOGICAL TREATMENT OF OUTBURSTS	10
IRRITABILITY: A CRITICAL DIMENSION OF PSYCHOPATHOLOGY	9
THE EFFECTS OF OUR CHANGING CLIMATE ON THE HEALTH AND MENTAL HEALTH OF INDIGENOUS CHILDREN AND FAMILIES GLOBALLY: PSYCHOLOGICAL AND ETHICAL CONSIDERATIONS	9
12.3 DIAGNOSTIC UTILITY OF THE CHILD BEHAVIOR CHECKLIST (CBCL)-BIPOLAR PROFILE FOR IDENTIFYING PEDIATRIC BIPOLAR I DISORDER	9
74.3 Dual Role of Child and Adolescent Psychiatrists in Integrated Care	9
6.2 ETHNIC/RACIAL IDENTITY AND DISCRIMINATION: IMPLICATIONS FOR ADOLESCENT AND YOUNG ADULT DEVELOPMENT	9
5.1 Epidemiology and Systems of Care Approaches for Addressing Structural Disparities in Child and Adolescent Psychiatry	9
4.1 New Post-RCT Open-Label Outcomes of Broad-Spectrum Multinutrients for Children With ADHD and Emotional Dysregulation: MADDY 16-Week Results	9
GUN LAWS AND YOUTH SUICIDE BY FIREARMS SYMPOSIUM: WHAT THE CLINICIAN NEEDS TO KNOW	9
PRECISION MEDICINE AND GENOMICALLY GUIDED TREATMENT IN AUTISM SPECTRUM DISORDER: ARE WE THERE YET?	9
3.5 Circadian Rhythms Sleep Disorders	9
RESEARCH INSTITUTE: CHILD AND ADOLESCENT PSYCHIATRY IN THE ERA OF GENOMICS	9
15.1 RATING SCALES FOR ANXIETY IN AUTISM SPECTRUM DISORDER	9
DIAGNOSTIC AND THERAPEUTIC DEVELOPMENTS IN INTELLECTUAL DEVELOPMENTAL DISORDER: WHAT'S NEXT?	9
SOCIAL MEDIA CONTAGION: A PARALLEL PANDEMIC?	9
2.2 INFLAMMATORY MARKERS, BRAIN-DERIVED NEUROTROPHIC FACTOR, AND THE SYMPTOMATIC COURSE OF ADOLESCENT BIPOLAR DISORDER: A PROSPECTIVE REPEATED-MEASURES STUDY	9
4.4 DO PRE-TRAUMA DEFICITS IN ATTENTION PREDICT ACUTE STRESS AND PTSD SYMPTOMS IN TRAUMA-EXPOSED YOUTH? RESULTS FROM THREE STUDIES	9
9.3 EARLY MANIFESTATIONS OF RISK FOR ADHD IN AT-RISK PRESCHOOL-AGED CHILDREN	9
1.3 Impact of Prenatal Cannabis Exposure on Neonatal Brain Connectivity	9
48.3 A Short-Term Partial Hospitalization Program for Youth with ASD and Developmental Disorders	8
2.5 Comparative Analysis of Individuals Who Commit Multicasualty Homicides in K-12 School Settings	8
7.4 FOOD INSECURITY AND EMOTIONAL DYSREGULATION IN CHILDREN WITH ADHD: THE MADDY STUDY	8
3.2 Sleep Education and Sleep Hygiene	8
43.15 Examination of the Location of Health Care Utilization Among Adolescents with Substance Use Disorders	8
7.3 Childhood Fluoride Exposure, DNA Methylation, and Mental Health	8
Inside Out 2	8
Editorial Board Page	8
Best of JAACAP Connect	8
Editorial: The Risks of Suicidality and Self-Harm in Adolescents During War: A Global Research Priority	8
40.2 Psychological IMPACT of Remote Learning in Children and Adolescents With Mental Health Disorders in the Community New York City Area	8
76.3 Finding a Way to Play With Things That Aren’t So Funny	8
8.2 Molecular Genetic Diagnostics and ASD: Relevance for Clinical Practice in the Era of Precision Medicine	8
3.4 YOUTH FIREARM VIOLENCE PREVENTION THROUGH RESPONSIBLE STORAGE COUNSELING AND ADVOCACY	8
1.126 Randomized Controlled Trial of Sleep Extension Therapy Using a Remote Support System in University Students With Increased Social Jetlag	8
Table of Contents	8
Reimagining Narrative Approaches Through Comics for Systems-Involved Youth	8
Scientific Content Regulations	8
39.2 The Roles of Mindfulness and Sleep Disturbance on the Relationship Between Avoidant Coping and Mental Health Symptoms During COVID-19	8
CANNABIS USE ACROSS THE LIFESPAN: IMPLICATIONS FOR PRENATAL AND ADOLESCENT NEURODEVELOPMENT	8
4.2 Blood Mineral Levels’ Role in Treatment Response to Multinutrients for ADHD and Emotional Dysregulation: The MADDY RCT	8
45.9 An Innovative Approach to Address the Child and Adolescent Psychiatry Shortage: Extended Consultation Model	8
43.10 The Effect of COVID-19 on the Substance Use Behaviors of First-Year College Students	8
After Yang	8
Happiness Falls	8
Lessons Learned From Magna-Tiles	7
What Happened to You? Conversations on Trauma, Resilience, and Healing	7
IMPLEMENTING FAMILY THERAPY OBSERVED STRUCTURED CLINICAL EXAMS (OSCES) TO PROVIDE COMPETENCY-BASED FORMATIVE EVALUATION TO CHILD AND ADOLESCENT PSYCHIATRY TRAINEES	7
Editorial: A Roadmap for Advancing the Field in Early-Onset Psychosis	7
Editorial Board	7
Editorial: Bringing Parenting Into Focus: A Decade of Longitudinal Follow-Up Reveals Potential Parenting Targets for Early Intervention for Adolescent Self-Injury	7
BUPRENORPHINE 1.0 (WAIVER TRAINING): PREPARING CHILD PSYCHIATRISTS TO TREAT OPIOID USE DISORDERS	7
20.3 Feasibility and Acceptability of a Peer-Delivered Substance Use Screening and Brief Intervention for Youth Attending an Adolescent Outpatient Clinic in Western Kenya	7
Editorial: How Can We Best Support Suicidal Youth? New Evidence for Dialectical Behavior Therapy and Different Forms of Self-Harm	7
Madness in the Family: Women, Care, and Illness in Japan	7
Council Page	7
CBT WITH YOUTH IN UNCERTAIN TIMES: INTERVENING EFFECTIVELY WITH FLEXIBILITY AND CREATIVITY	7
Editorial Board Page	7
Psychedelic Therapeutics for Adolescents: Ethics, Safety, Opportunities, and Equipoise—Authors' Reply	7
SIMON WILE SYMPOSIUM: FOCUS ON DIVERSITY AND EQUITY THROUGH A PEDIATRIC COLLABORATIVE AND INTEGRATED CARE LENS	6
29.2 Crisis Afar: An International Collaboration to Examine the Heterogeneous Outcomes of the COVID-19 Pandemic in Youth With Neurodevelopmental Conditions	6
10.4 Development of Measurement-Based Care in a Mental Health Setting of Children and Adolescents	6
35.2 PARTNERSHIP AND ADAPTATION TO IMPLEMENT TRAUMA-FOCUSED CBT (TF-CBT) IN A LOW-RESOURCED AND POSTDISASTER CONTEXT: THE CASE OF PUERTO RICO	6
21.2 MULTIMETHOD INVESTIGATION OF THE NEUROBIOLOGICAL BASIS OF ADHD SYMPTOMATOLOGY IN CHILDREN AGES 9 AND 10: BASELINE DATA FROM THE ABCD STUDY	6
GENOMICS TO THERAPEUTICS FOR ASD: PROMISE AND CHALLENGES	6